ENTITY

Intercept Pharmaceuticals (ICPT US)

27
Analysis
Health CareUnited States
Intercept Pharmaceuticals, Inc. manufactures and markets biopharmaceutical products. The Company focuses on the development and commercialization of therapeutics to treat chronic liver diseases utilizing proprietary bile acid chemistry. Intercept Pharmaceuticals serves customers throughout the United States.
more
Company Event02 Nov 2023 20:00 • Upcoming
Add To Calendar
Company Event14 Sep 2023 03:10 • Latest
Company Event02 Aug 2023 20:30
Company Event23 Jun 2023 20:30
Company Event22 May 2023 20:30
x